Search All UT System Experts

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non–Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked

J. Nicholas Bodor, Jyoti D. Patel, Heather A. Wakelee, Benjamin P. Levy, Hossein Borghaei, Bruna Pellini, Michael R. Costello, Jonathan E. Dowell, Gene Finley, Chao H. Huang, Joel W. Neal, Jorge J. Nieva, Sonam Puri, Mark A. Socinski, Christian Thomas, Eric A. Ross, Samuel Litwin, Margie L. Clapper, Joseph Treat

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non–Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked'. Together they form a unique fingerprint.

Medicine & Life Sciences